CN Patent

CN102470135A — 抑制jak途径的组合物和方法

Assigned to Rigel Pharmaceuticals Inc · Expires 2012-05-23 · 14y expired

What this patent protects

化合物I和II以及盐和含有它们的药物组合物可用于治疗眼睛的疾病和/或病症。

USPTO Abstract

化合物I和II以及盐和含有它们的药物组合物可用于治疗眼睛的疾病和/或病症。

Drugs covered by this patent

Patent Metadata

Patent number
CN102470135A
Jurisdiction
CN
Classification
—
Expires
2012-05-23
Drug substance claim
No
Drug product claim
No
Assignee
Rigel Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.